Evidence vs. efficacy in allergen-specific immunotherapy: Considerations using the example of tradable products in Germany
Crossref DOI link: https://doi.org/10.1007/s40629-016-0096-2
Published Online: 2016-03-23
Published Print: 2016-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brehler, Randolf
Klimek, Ludger
Vogelberg, Christian
Werfel, Thomas
Pfaar, Oliver
Hamelmann, Eckard
Text and Data Mining valid from 2016-03-01
Version of Record valid from 2016-03-23
Article History
Received: 7 December 2015
Accepted: 26 January 2016
First Online: 23 March 2016